Financial Statements — PRZO
Balance Sheet
(in millions USD)| Metric | Q2
2025 | Q2
2023 |
|---|
| Cash & Equivalents | 2.37 | 0.08 |
| Short-term Investments | 2.50 | -- |
| Accounts Receivable | 0.04 | 0.02 |
| Inventory | 0.34 | 0.34 |
| Total Current Assets | 5.79 | 0.96 |
| Property, Plant & Equipment | 0.11 | 0.03 |
| Total Non-current Assets | 0.54 | 0.06 |
| Total Assets | 6.33 | 1.02 |
| Total Current Liabilities | 1.24 | 3.00 |
| Total Non-current Liabilities | 1.57 | 0.41 |
| Total Liabilities* | 2.80 | 3.00 |
| Retained Earnings | -- | 2.00 |
| Total Stockholder Equity | 3.53 | (1.97) |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2025 | Q2
2023 |
|---|
| Total Revenue | 0.36 | 0.34 |
| Cost of Revenue | 0.43 | 0.19 |
| Gross Profit | (0.07) | 0.15 |
| Research & Development | 1.16 | 0.22 |
| Selling, General & Admin | 1.67 | 0.10 |
| Total Operating Expenses | 3.58 | 0.52 |
| Operating Income | (3.65) | (0.37) |
| Net Income | (2.30) | (0.43) |
| Basic EPS | (0.14) | 0.12 |
| Diluted EPS | (0.14) | 0.12 |
Cash Flow Statement
(in millions USD)| Metric | Q2
2025 | Q2
2023 |
|---|
| Operating Cash Flow | (3.07) | (0.25) |
| Capital Expenditures | 0.02 | 0.00 |
| Free Cash Flow* | (3.09) | (0.25) |
| Investing Cash Flow | (2.53) | -0.00 |
| Financing Cash Flow | 3.79 | 0.25 |
* Derived from reported values
